Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma

Clin Genitourin Cancer. 2017 Oct;15(5):e893-e895. doi: 10.1016/j.clgc.2017.05.021. Epub 2017 May 25.
No abstract available

Keywords: Discoid domain receptor-2; Genome sequencing; Long term survival; Metastatic ACC; Mitotane.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Neoplasms / diagnostic imaging
  • Adrenal Cortex Neoplasms / genetics
  • Adrenal Cortex Neoplasms / therapy*
  • Adrenalectomy
  • Adrenocortical Carcinoma / diagnostic imaging
  • Adrenocortical Carcinoma / genetics
  • Adrenocortical Carcinoma / therapy*
  • Carboplatin / therapeutic use
  • Combined Modality Therapy / methods*
  • Discoidin Domain Receptor 2 / genetics*
  • Disease-Free Survival
  • Doxorubicin / therapeutic use
  • Etoposide / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Mitotane / therapeutic use
  • Mutation
  • Neoplasm Metastasis
  • Nephrectomy
  • Tomography Scanners, X-Ray Computed

Substances

  • Etoposide
  • Mitotane
  • Doxorubicin
  • Carboplatin
  • DDR2 protein, human
  • Discoidin Domain Receptor 2